Kobo Biotech Ltd.
Snapshot View

4.75 -0.25 ▼-5.0%

02 December 2022, 04:01:00 PM
Volume: 11,647

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.avonlifesciences.com
Market Cap 11.32 Cr.
Enterprise Value(EV) 151.65 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -6.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.40 Trailing Twelve Months Ending 2022-09
Book Value / Share -52.46 Trailing Twelve Months Ending 2022-09
Price to Book Value -0.09 Calculated using Price: 4.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 2.38 Cr. 23,825,000 Shares
FaceValue 10
Company Profile
AVON Organics Limited (AOL) was started by P R Agarwal, Rajesh Agarwal along with late G S Sidhu .It is located at Madhupala Towers Greenlands, Hyderabad 500 016, India. The company's transition from a machinery manufacturer to a full-fledged chemical manufacturer saw the company foraying into the highly technology-intensive area of Diketene and its derivatives.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-5.00%
1 Week
-10.71%
1 Month
+1.06%
3 Month
-8.65%
6 Month
-4.62%
1 Year
-12.52%
2 Year
-31.26%
5 Year
-66.67%
10 Year
-82.54%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -53.52 -103.90 -233.98
Return on Capital Employed (%) -7.12 -8.67 -1.32 -2.78 -5.12 -5.74 -3.93 -5.31 -17.59
Return on Assets (%) -11.70 -11.40 -6.43 -7.50 -9.60 -10.08 -8.83 -8.24 -9.83

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 45 14 6 -19 -43 -67 -88 -107 -122 -125
Non Curr. Liab. 79 74 74 64 47 40 40 39 38 38
Curr. Liab. 155 164 180 207 242 266 284 299 163 164
Minority Int.
Equity & Liab. 279 252 260 252 246 239 236 231 79 77
Non Curr. Assets 118 110 102 95 89 83 77 71 42 40
Curr. Assets 161 142 158 157 157 157 159 159 38 38
Misc. Exp. not W/O
Total Assets 279 252 260 252 246 239 236 231 79 77

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 57 29 33
Other Income 3 1 1 6 0 1 2 0 133 0
Total Income 60 30 34 6 0 1 2 0 133 0
Total Expenditure -64 -39 -29 -4 -3 -3 -3 -3 -144 -10
PBIDT -4 -9 5 2 -3 -2 -1 -3 -10 -10
Interest -18 -16 -14 -14 -15 -14 -14 -11 0
Depreciation -10 -8 -7 -7 -6 -6 -6 -6 -5 -4
Taxation -1
Exceptional Items 3 -2
PAT -33 -30 -16 -19 -24 -24 -21 -19 -15 -14
Adjusted EPS -14 -13 -7 -8 -10 -10 -9 -8 -6 -6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 38 11 19 6 32 31 21 14 3 94
Cash Fr. Inv. -8 -5 25
Cash Fr. Finan. -36 -7 -21 -5 -33 -31 -21 -14 -1 -120
Net Change -6 -1 -1 0 0 1 -1
Cash & Cash Eqvt 2 1 0 1 0 0 0 0 2 0

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95 44.95
Public 55.05 55.05 55.05 55.05 55.05 55.05 55.05 55.05 55.05
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 29 Nov 2022
Disclosure Of Related Party Transactions For The Half Year Ended 30Th September 2022 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (''Listing Regulations'')
Disclosure of Related Party Transactions for the half year ended 30th September 2022 pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations)
Mon, 14 Nov 2022
Board Meeting Outcome for OUTCOME OF THE BOARD MEETING: Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2022
The Board of Directors of Kobo Biotech Limited at their meeting held today i.e. on Monday 14th November 2022 inter alia approved the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2022 along with the Limited review report of statutory auditor thereon.
Mon, 07 Nov 2022
Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The Half Year And 2Nd Quarter Ended 30Th September 2022
Kobo Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th November 2022 inter alia to consider and approve the unaudited financial results of the Company for the half year and 2nd quarter ended 30th September 2022.

Technical Scans View Details >>

Fri, 02 Dec 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,530.84 1,040.00 -0.6%
Cipla Ltd. 89,936.23 1,114.35 -0.9%
Divi's Laboratories Ltd. 89,761.56 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. 75,098.21 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. 70,043.98 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. 54,931.39 1,623.05 -1.2%
Max Healthcare Institute Ltd. 43,491.25 448.10 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.50 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 35.23 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.99 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 24.23 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 83.18 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.92 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 46.09 448.10 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.68 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-09 4.13 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.40 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.63 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.67 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.02 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-09 6.29 448.10 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 448.10 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 448.10 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 448.10 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.00 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,114.35 -0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,381.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.40 +0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,871.45 +2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,623.05 -1.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 448.10 -0.9%

FAQ's On Kobo Biotech Ltd.

What is Kobo Biotech share price?

Can I buy Kobo Biotech shares now?

What is the Market Cap of Kobo Biotech?

What is the 52 Week High and Low of Kobo Biotech?

What is the trend of Kobo Biotech share price?